These drugs mimic or enhance the effects of incretins, which are hormones that stimulate insulin release from the pancreas in response to meals. Through improving insulin secretion and reducing ...

The rising prevalence of obesity has prompted the development of effective weight loss treatments. Several peptide hormones have a key role in appetite regulation and metabolism, but the discovery ...

Yancy also talked about improved knowledge about risk modification for conditions like hypertension and the “continued explosion of the use of the incretin therapies in the cardiovascular space.” ...

Citation: Study suggests lean muscle mass loss can be minimized during weight loss therapy using newer incretin obesity drugs (2025, April 10) retrieved 19 April 2025 from https://medicalxpress ...

New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for ...

"We are pleased to see that our latest incretin medicine meets our expectations for safety and tolerability, glucose control and weight loss, and we look forward to additional data readouts later ...

"We are pleased to see that our latest incretin medicine meets our expectations for safety and tolerability, glucose control, and weight loss, and we look forward to additional data readouts later ...

Still, Eli Lilly is "pleased to see that our latest incretin medicine meets our expectations for safety and tolerability, glucose control and weight loss, and we look forward to additional data ...

These clinical trials aim to better understand the effects of potential anti-cancer and protective agents, including aspirin, omega-3-fatty acids, coffee and incretin mimetics (GLP1-receptor ...